Senior insider sale
Chief Medical Officer at VERICEL CORP — senior position signals high conviction
$422.4K
11.65K shares
What this filing means
HOPPER JONATHAN MARK plans to sell 11.65K shares of VERICEL CORP valued at approximately $422.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/2/2025ACC: 0001959173-25-007415
Officer· Chief Medical Officer
Since Feb 2020
11.65K
Shares to sell
$422.4K
Approx. market value
1.65K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Option Granted - 02/11/2020
Cash
12/2/2025
1.65KTotal acquired1.65K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/2/2025 | Option Granted - 02/11/2020 Cash | 1.65K | — |
| Total | 1.65K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10K
Market value
$357.7K
9/2/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.65K
Market value
$64.7K
12/2/2025
Total
Units
11.65K
Value
$422.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/2/2025 | 10K | $357.7K | — | Completed |
| Planned — Approximate Date | ||||
12/2/2025 | 1.65K | $64.7K | NASDAQ | Planned |
| Total | 11.65K | $422.4K | ||